Ferrostatin-1 (Fer-1) inhibits ferroptosis, a form of regulated, oxidative, nonapoptotic cell death. We found that Fer-1 inhibited cell death in cellular models of Huntington’s disease (HD), periventricular leukomalacia (PVL), and kidney dysfunction; Fer-1 inhibited lipid peroxidation, but not mitochondrial reactive oxygen species formation or lysosomal membrane permeability. We developed a mechanistic model to explain the activity of Fer-1, which guided the development of ferrostatins with improved properties. These studies suggest numerous therapeutic uses for ferrostatins, and that lipid peroxidation mediates diverse disease phenotypes.
Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
R. Skouta,S. Dixon,Jianlin Wang,Denise E. Dunn,M. Orman,K. Shimada,P. Rosenberg,D. Lo,J. Weinberg,A. Linkermann,B. Stockwell
Published 2014 in Journal of the American Chemical Society
ABSTRACT
PUBLICATION RECORD
- Publication year
2014
- Venue
Journal of the American Chemical Society
- Publication date
2014-03-04
- Fields of study
Medicine, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-43 of 43 references · Page 1 of 1